{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:50:09Z","timestamp":1791111009791,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.1023\/a:1025635720208","type":"journal-article","created":{"date-parts":[[2003,9,23]],"date-time":"2003-09-23T22:47:08Z","timestamp":1064357228000},"page":"673-680","source":"Crossref","is-referenced-by-count":36,"title":["A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women's health in the Lund area (WHILA) study (Sweden)"],"prefix":"10.1007","volume":"14","author":[{"given":"Helena","family":"Jernstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4r-Ola","family":"Bendahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Lidfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Nerbrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl-David","family":"Agardh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran","family":"Samsioe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"2","key":"5139817_CR1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s001980200010","volume":"13","author":"S Arrenbrecht","year":"2002","unstructured":"Arrenbrecht S, Boermans AJ (2002) Effects of transdermal estradiol delivered by a matrix patch on bone density in hysterectomized, postmenopausal women: a 2-year placebo-controlled trial. Osteoporos Int\n13(2): 176-183.","journal-title":"Osteoporos Int"},{"issue":"7","key":"5139817_CR2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","volume":"280","author":"S Hulley","year":"1998","unstructured":"Hulley S, Grady D, Bush T, et al. (1998) Randomized trial of estrogen plus progesin for secondary prevention of coronary heart disease in postmenopausal women. JAMA\n280(7): 605-613.","journal-title":"JAMA"},{"issue":"4","key":"5139817_CR3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/hc2901.092200","volume":"104","author":"L Mosca","year":"2001","unstructured":"Mosca L, Collins P, Herrington DM, et al. (2001) Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation\n104(4): 499-503.","journal-title":"Circulation"},{"issue":"7101","key":"5139817_CR4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/bmj.315.7101.149","volume":"315","author":"E Hemminki","year":"1997","unstructured":"Hemminki E, McPherson K (1997) Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials. Br Med J\n315(7101): 149-153.","journal-title":"Br Med J"},{"issue":"3","key":"5139817_CR5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE, Anderson GL, Prentice RL, et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA\n288(3): 321-333.","journal-title":"JAMA"},{"issue":"5","key":"5139817_CR6","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1054\/bjoc.2001.1899","volume":"85","author":"H Olsson","year":"2001","unstructured":"Olsson H, Bladstr\u00f6m A, Ingvar C, M\u00f6ller TR (2001) A population-based cohort study of HRT use and breast cancer in southern Sweden. Br J Cancer\n85(5): 674-677.","journal-title":"Br J Cancer"},{"key":"5139817_CR7","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","volume":"350","author":"Collaborative group on hormonal factors in breast cancer","year":"1997","unstructured":"Collaborative group on hormonal factors in breast cancer(1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet\n350: 1047-1059.","journal-title":"Lancet"},{"issue":"9","key":"5139817_CR8","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/sj.bjc.6690543","volume":"80","author":"H Jernstr\u00f6m","year":"1999","unstructured":"Jernstr\u00f6m H, Frenander J, Ferno M, Olsson H (1999) Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients. Br J Cancer\n80(9): 1453-1458.","journal-title":"Br J Cancer"},{"issue":"3","key":"5139817_CR9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.0.CO;2-6","volume":"81","author":"C Magnusson","year":"1999","unstructured":"Magnusson C, Baron JA, Correia N, Bergstrom R, Adami HO, Persson I (1999) Breast-cancer risk following long-term oestrogenand oestrogen-progestin-replacement therapy. Int J Cancer\n81(3): 339-344.","journal-title":"Int J Cancer"},{"issue":"4","key":"5139817_CR10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/jama.283.4.485","volume":"283","author":"C Schairer","year":"2000","unstructured":"Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R (2000) Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA\n283(4): 485-491.","journal-title":"JAMA"},{"issue":"6","key":"5139817_CR11","first-page":"1148","volume":"100","author":"LK Weiss","year":"2002","unstructured":"Weiss LK, Burkman RT, Cushing-Haugen KL, Voigt LF, Simon MS, Daling JR, et al. (2002) Hormone replacement therapy regimens and breast cancer risk(1). Obstet Gynecol\n100(6): 1148-1158.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"5139817_CR12","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/humrep\/17.5.1379","volume":"17","author":"C Li","year":"2002","unstructured":"Li C, Wilawan K, Samsioe G, Lidfeldt J, Agardh CD, Nerbrand C (2002) Health profile of middle-aged women: The Women's Health in the Lund Area (WHILA) study. Hum Reprod\n17(5): 1379-1385.","journal-title":"Hum Reprod"},{"issue":"2","key":"5139817_CR13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/meta.2002.300001","volume":"51","author":"J Lidfeldt","year":"2002","unstructured":"Lidfeldt J, Holmdahl L, Samsioe G, et al. (2002) The influence of hormonal status and features of the metabolic syndrome on bone density: a population-based study of Swedish women aged 50 to 59 years. The women's health in the Lund area study. Metabolism\n51(2): 267-270.","journal-title":"Metabolism"},{"key":"5139817_CR14","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/bjc.1994.192","volume":"69","author":"R Simon","year":"1994","unstructured":"Simon R, Altman DG (1994) Statistical aspects of prognostic factor studies. Br J Cancer\n69: 979-985.","journal-title":"Br J Cancer"},{"issue":"8","key":"5139817_CR15","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/oxfordjournals.aje.a009515","volume":"147","author":"MC Pike","year":"1998","unstructured":"Pike MC, Ross RK, Spicer DV (1998) Problems involved in including women with simple hysterectomy in epidemiologic studies measuring the effects of hormone replacement therapy on breast cancer risk. Am J Epidemiol\n147(8): 718-721.","journal-title":"Am J Epidemiol"},{"issue":"10-11","key":"5139817_CR16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0039-128X(00)00122-7","volume":"65","author":"MC Pike","year":"2000","unstructured":"Pike MC, Ross RK (2000) Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer. Steroids\n65(10-11): 659-664.","journal-title":"Steroids"},{"issue":"7358","key":"5139817_CR17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/bmj.325.7358.239","volume":"325","author":"M Wells","year":"2002","unstructured":"Wells M, Sturdee DW, Barlow DH, et al. (2002) Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study. Br Med J\n325(7358): 239.","journal-title":"Br Med J"},{"key":"5139817_CR18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF01806214","volume":"40","author":"H Olsson","year":"1996","unstructured":"Olsson H, Jernstr\u00f6m H, Alm A, et al. (1996) Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use and reproductive factors. Breast Cancer Res Treat\n40: 187-196.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"5139817_CR19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF01805718","volume":"2","author":"J Russo","year":"1982","unstructured":"Russo J, Tay L, Russo I (1982) Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat\n2(1): 5-73.","journal-title":"Breast Cancer Res Treat"},{"issue":"23","key":"5139817_CR20","first-page":"7415","volume":"50","author":"S Preston-Martin","year":"1990","unstructured":"Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE (1990) Increased cell division as a cause of human cancer. Cancer Res\n50(23): 7415-7421.","journal-title":"Cancer Res"},{"key":"5139817_CR21","volume-title":"Lilla br\u00f6stboken-nytt om hormoneffekter p\u00e5 br\u00f6stv\u00e4vnad","author":"G S\u00f6derqvist","year":"2002","unstructured":"S\u00f6derqvist G, Leifland K, Olsson H, J\u00e4rbrink K (2002) Lilla br\u00f6stboken-nytt om hormoneffekter p\u00e5 br\u00f6stv\u00e4vnad. V\u00e4stra Fr\u00f6lunda: Organon AB."},{"issue":"1","key":"5139817_CR22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/cmt.4.1.7.12","volume":"4","author":"P Conner","year":"2001","unstructured":"Conner P, Skoog L, Soderqvist G (2001) Breast epithelial proliferation in postmenopausal women evaluated through fineneedle-aspiration cytology. Climacteric\n4(1): 7-12.","journal-title":"Climacteric"},{"issue":"4","key":"5139817_CR23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/jnci\/92.4.328","volume":"92","author":"RK Ross","year":"2000","unstructured":"Ross RK, Paganini-Hill A, Wan PC, Pike MC (2000) Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst\n92(4): 328-332.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"5139817_CR24","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1002\/1097-0142(197605)37:5<2486::AID-CNCR2820370542>3.0.CO;2-8","volume":"37","author":"JN Wolfe","year":"1976","unstructured":"Wolfe JN (1976) Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer\n37(5): 2486-2492.","journal-title":"Cancer"},{"issue":"12","key":"5139817_CR25","first-page":"1133","volume":"7","author":"NF Boyd","year":"1998","unstructured":"Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ (1998) Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev\n7(12): 1133-1144.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"5139817_CR26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0002-9378(99)70560-0","volume":"181","author":"E Lundstr\u00f6m","year":"1999","unstructured":"Lundstr\u00f6m E, Wilczek B, von Palffy Z, S\u00f6derqvist G, von Schoultz B (1999) Mammographic breast density during hormone replacement therapy: differences according to treatment. Am J Obstet Gynecol\n181(2): 348-352.","journal-title":"Am J Obstet Gynecol"},{"key":"5139817_CR27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0015-0282(01)01967-7","volume":"76","author":"N Colacurci","year":"2001","unstructured":"Colacurci N, Fornaro F, De Franciscis P, Mele D, Palermo M, del Vecchio W (2001) Effects of short time suspension of hormone replacement therapy on mammographic density. Fertil Steril\n76: 451-455.","journal-title":"Fertil Steril"},{"issue":"9200","key":"5139817_CR28","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0140-6736(99)07319-5","volume":"355","author":"AM Kavanagh","year":"2000","unstructured":"Kavanagh AM, Mitchell H, Giles GG (2000) Hormone replacement therapy and accuracy of mammographic screening. Lancet\n355(9200): 270-274.","journal-title":"Lancet"},{"issue":"1","key":"5139817_CR29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0277-5379(88)90173-3","volume":"24","author":"T Key","year":"1988","unstructured":"Key T, Pike M (1988) The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol\n24(1): 29-43.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"5139817_CR30","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/jnci\/87.17.1297","volume":"87","author":"SE Hankinson","year":"1995","unstructured":"Hankinson SE, Willett WC, Manson JE, et al. (1995) Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst\n87: 1297-1302.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"5139817_CR31","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0002-9343(97)00025-9","volume":"103","author":"KE Ensrud","year":"1997","unstructured":"Ensrud KE, Lipschutz RC, Cauley JA, et al. (1997) Body size and hip fracture risk in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Am J Med\n103(4): 274-280.","journal-title":"Am J Med"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1025635720208.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1025635720208\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1025635720208.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T18:05:58Z","timestamp":1750961158000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1025635720208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["5139817"],"URL":"https:\/\/doi.org\/10.1023\/a:1025635720208","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9]]}}}